1. Home
  2. MIAX vs WVE Comparison

MIAX vs WVE Comparison

Compare MIAX & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MIAX

Miami International Holdings Inc.

N/A

Current Price

$43.99

Market Cap

3.8B

Sector

Finance

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$15.74

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIAX
WVE
Founded
2007
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.2B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
MIAX
WVE
Price
$43.99
$15.74
Analyst Decision
Buy
Strong Buy
Analyst Count
6
16
Target Price
$47.20
$29.94
AVG Volume (30 Days)
1.2M
13.7M
Earning Date
02-22-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,318,535,000.00
$109,230,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$19.04
$16.00
P/E Ratio
N/A
N/A
Revenue Growth
22.86
103.75
52 Week Low
$28.63
$5.28
52 Week High
$51.38
$21.73

Technical Indicators

Market Signals
Indicator
MIAX
WVE
Relative Strength Index (RSI) N/A 55.08
Support Level N/A $15.23
Resistance Level N/A $18.50
Average True Range (ATR) 0.00 1.18
MACD 0.00 -0.34
Stochastic Oscillator 0.00 16.51

Price Performance

Historical Comparison
MIAX
WVE

About MIAX Miami International Holdings Inc.

Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: